This article has Open Peer Review reports available.
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial
- Andreas Tomaschitz†1Email author,
- Astrid Fahrleitner-Pammer2,
- Burkert Pieske1,
- Nicolas Verheyen1,
- Karin Amrein2,
- Eberhard Ritz3,
- Katharina Kienreich2,
- Jörg H Horina4,
- Albrecht Schmidt1,
- Elisabeth Kraigher-Krainer1,
- Caterina Colantonio1,
- Andreas Meinitzer5 and
- Stefan Pilz†2, 6Email author
© Tomaschitz et al.; licensee BioMed Central Ltd. 2012
Received: 15 February 2012
Accepted: 31 August 2012
Published: 13 September 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|15 Feb 2012||Submitted||Original manuscript|
|8 Mar 2012||Author responded||Author comments - Andreas Tomaschitz|
|Resubmission - Version 2|
|8 Mar 2012||Submitted||Manuscript version 2|
|18 Mar 2012||Reviewed||Reviewer Report - laurent brunaud|
|8 May 2012||Reviewed||Reviewer Report - Gian Paolo Rossi|
|10 May 2012||Reviewed||Reviewer Report - Per Hellman|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|28 Aug 2012||Reviewed||Reviewer Report - Gian Paolo Rossi|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|31 Aug 2012||Editorially accepted|
|13 Sep 2012||Article published||10.1186/1472-6823-12-19|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.